Andrew Baum's most recent trade in Pfizer Inc. was a trade of 206,569 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | Andrew Baum | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 206,569 | 206,569 | - | - | Stock Appreciation Rights |